183 related articles for article (PubMed ID: 30696421)
41. Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells.
Alfonso-Jaume MA; Mahimkar R; Lovett DH
Biochem J; 2004 Jun; 380(Pt 3):735-47. PubMed ID: 14979875
[TBL] [Abstract][Full Text] [Related]
42. Interaction with SP1, but not binding to the E-box motifs, is responsible for BHLHE40/DEC1-induced transcriptional suppression of CLDN1 and cell invasion in MCF-7 cells.
Zheng Q; Wang C; Wang L; Zhang D; Liu N; Ming X; Zhou H; Guli Q; Liu Y
Mol Carcinog; 2018 Sep; 57(9):1116-1129. PubMed ID: 29704436
[TBL] [Abstract][Full Text] [Related]
43. NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
Perotti V; Baldassari P; Molla A; Vegetti C; Bersani I; Maurichi A; Santinami M; Anichini A; Mortarini R
Oncogene; 2016 Jun; 35(22):2862-72. PubMed ID: 26387540
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells.
Clem AL; Hamid T; Kakar SS
Gene; 2003 Dec; 322():113-21. PubMed ID: 14644503
[TBL] [Abstract][Full Text] [Related]
45. Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells.
Lu S; Archer MC
Int J Cancer; 2010 Jan; 126(2):416-25. PubMed ID: 19621387
[TBL] [Abstract][Full Text] [Related]
46. Ligand activated hPR modulates the glycodelin promoter activity through the Sp1 sites in human endometrial adenocarcinoma cells.
Gao J; Mazella J; Seppala M; Tseng L
Mol Cell Endocrinol; 2001 May; 176(1-2):97-102. PubMed ID: 11369448
[TBL] [Abstract][Full Text] [Related]
47. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
Tang Q; Wu J; Zheng F; Hann SS; Chen Y
Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
[TBL] [Abstract][Full Text] [Related]
48. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.
Jia Z; Zhang J; Wei D; Wang L; Yuan P; Le X; Li Q; Yao J; Xie K
Cancer Res; 2007 May; 67(10):4878-85. PubMed ID: 17510417
[TBL] [Abstract][Full Text] [Related]
49. Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acid.
Singh SK; Baumgart S; Singh G; König AO; Reutlinger K; Hofbauer LC; Barth P; Gress TM; Lomberk G; Urrutia R; Fernandez-Zapico ME; Ellenrieder V
J Biol Chem; 2011 Aug; 286(33):28761-28771. PubMed ID: 21628454
[TBL] [Abstract][Full Text] [Related]
50. Role of the CCAAT/enhancer-binding protein NFATc2 transcription factor cascade in the induction of secretory phospholipase A2.
Yang TT; Ung PM; Rincón M; Chow CW
J Biol Chem; 2006 Apr; 281(17):11541-52. PubMed ID: 16500900
[TBL] [Abstract][Full Text] [Related]
51. Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer.
Koizume S; Ito S; Nakamura Y; Yoshihara M; Furuya M; Yamada R; Miyagi E; Hirahara F; Takano Y; Miyagi Y
Mol Cancer; 2015 Apr; 14():77. PubMed ID: 25879517
[TBL] [Abstract][Full Text] [Related]
52. Nectin-2 expression in testicular cells is controlled via the functional cooperation between transcription factors of the Sp1, CREB, and AP-1 families.
Lui WY; Sze KL; Lee WM
J Cell Physiol; 2006 Apr; 207(1):144-57. PubMed ID: 16250013
[TBL] [Abstract][Full Text] [Related]
53. A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells.
Guo D; Wu B; Yan J; Li X; Sun H; Zhou D
Biochem Biophys Res Commun; 2012 Nov; 428(1):80-5. PubMed ID: 23047008
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional regulation of the human CD3 gamma gene: the TATA-less CD3 gamma promoter functions via an initiator and contiguous Sp-binding elements.
Badran BM; Kunstman K; Stanton J; Moschitta M; Zerghe A; Akl H; Burny A; Wolinsky SM; Willard-Gallo KE
J Immunol; 2005 May; 174(10):6238-49. PubMed ID: 15879122
[TBL] [Abstract][Full Text] [Related]
55. Anti-fibrotic effects via regulation of transcription factor Sp1 on hepatic stellate cells.
Chen H; Zhou Y; Chen KQ; An G; Ji SY; Chen QK
Cell Physiol Biochem; 2012; 29(1-2):51-60. PubMed ID: 22415074
[TBL] [Abstract][Full Text] [Related]
56. Estrogen receptor α (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins.
Tu CC; Kumar VB; Day CH; Kuo WW; Yeh SP; Chen RJ; Liao CR; Chen HY; Tsai FJ; Wu WJ; Huang CY
J Mol Endocrinol; 2013; 51(1):203-12. PubMed ID: 23733894
[TBL] [Abstract][Full Text] [Related]
57. Conserved POU-binding site linked to SP1-binding site within FZD5 promoter: Transcriptional mechanisms of FZD5 in undifferentiated human ES cells, fetal liver/spleen, adult colon, pancreatic islet, and diffuse-type gastric cancer.
Katoh Y; Katoh M
Int J Oncol; 2007 Mar; 30(3):751-5. PubMed ID: 17273778
[TBL] [Abstract][Full Text] [Related]
58. Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.
Hedrick E; Cheng Y; Jin UH; Kim K; Safe S
Oncotarget; 2016 Apr; 7(16):22245-56. PubMed ID: 26967243
[TBL] [Abstract][Full Text] [Related]
59. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
60. Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells.
Sankpal UT; Goodison S; Jones-Pauley M; Hurtado M; Zhang F; Basha R
Oncotarget; 2017 Feb; 8(9):14593-14603. PubMed ID: 28099934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
